Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin.
about
Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosisbeta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection.Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis.Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.Time correlation between mononucleosis and initial symptoms of MS.Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γActivation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.Changes in tonsil B cell phenotypes and EBV receptor expression in children under 5 years old.Secondary NAD+ deficiency in the inherited defect of glutamine synthetase.Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.Human memory B cells isolated from blood and tonsils are functionally distinctive.Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production.Optimisation of ex vivo memory B cell expansion/differentiation for interrogation of rare peripheral memory B cell subset responses.
P2860
Q28540781-97761F85-5C54-4CD9-9D78-3FA62691C717Q33990687-E99A9D12-1374-4DCA-B127-A99875BBF4D8Q34174575-CD05FB07-DC22-42F6-ADDA-692812CDEBF8Q34270452-88097450-3874-4B10-9C62-054CE2E48B36Q34703035-0C934254-D12F-41DA-B8BE-C9302EADDB16Q35598260-A7AAA457-E3C6-40D8-8507-BE06DC9D9446Q37671515-47710151-7764-4880-895F-BE1C3C59EB95Q37701554-26DDDE2C-B710-4130-94E3-AB884B69F903Q37701620-E9A7062F-862B-40AB-8B9F-3167180B79E2Q37736423-9D2A95DD-F17F-496A-BC61-27FA55F6A515Q39609877-A114ED6B-77B1-41CC-A97C-33B35206D6C7Q40051009-AA01B6B6-AB2D-47C5-B86F-330F2FCE43AAQ41035824-3D9D87C1-DBF2-4C28-B78E-FA9A3726A434Q42264347-5F6A0FAB-6424-44A2-9E23-BE94F8E59622Q50791415-EB0C75AD-C2FB-4826-9D92-58611AE68D10Q51888725-CA009DD4-6707-4CA9-85DF-9F5DA7BF4AE7Q52626499-4C3728F4-7C91-49DB-B902-8D9310B7B7FD
P2860
Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@ast
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@en
type
label
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@ast
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@en
prefLabel
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@ast
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@en
P2093
P2860
P50
P356
P1433
P1476
Distinct ex vivo susceptibilit ...... tion status and tissue origin.
@en
P2093
Christoph Berger
David Nadal
Franziska Zucol
Gregory T Melroe
Rahel Byland
P2860
P304
P356
10.1128/JVI.02630-07
P407
P577
2008-03-05T00:00:00Z